Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. (Q45847612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

Maurizia R Brunetto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

L Fiume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M R Cerenzia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

C Busi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

A Mattioli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

E Chiaberge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

G Verme

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

language of work or name

English

0 references

publication date

1 July 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

8601

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

13-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection

29 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Drug targeting in antiviral chemotherapy. A chemically stable conjugate of 9-beta-D-arabinofuranosyl-adenine 5'-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Conjugates of adenine 9-α-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Pharmacology, Tolerance, and Antiviral Activity of Vidarabine Monophosphate in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

Effects of Interferon and Adenine Arabinoside Treatment of Hepatitis B Virus Infection on Cellular Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992946-7

7 January 2021

10.1016/S0140-6736(88)92946-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2455204%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference